Dexamethasone-facilitated postponement of delivery of an extremely preterm pregnancy complicated by the syndrome of hemolysis, elevated liver enzymes, and low platelets

Military Medicine

Volumn 164, Issue 4, 1999, Pages 316-318

  O'Boyle, John D ^a   Magann, Everett F ^a   Waxman, Erna ^a   Martin Jr , James N ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDRALAZINE; LABETALOL; METHYLDOPA;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; FETUS MATURITY; FETUS OUTCOME; HELLP SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MATERNAL HYPERTENSION; ORAL DRUG ADMINISTRATION; PREMATURE LABOR;

EID: 0345491475     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/164.4.316     Document Type: Article

References (12)

1. Sibai BM, Akl S, Fairlie F, Moretti M: A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990; 163: 733-8.
2. Sibai BM, Mercer BM, Schiff E, Friedman SA: Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818-22.
3. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN Jr: Ante-partum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP), Am J Obstet Gynecol 1994; 171: 1148-53.
4. Clark SL, Phelan JR, Allen SH, Golde SR: Antepartum reversal of hematologic abnormalities associated with the HELLP syndrome. J Reprod Med 1986; 31: 70-2.
5. Magann EF, Washburne JF, Sullivan CA, Schorr SJ, Morrison JC, Martin JN Jr. Corticosteroid-induced arrest of HELLP syndrome progression in a marginally-viable pregnancy. Eur J Obstet Gynecol Reprod Biol 1995; 59: 217-9.
6. Heller CS, Elliott JP: High order multiple pregnancies complicated by HELLP syndrome: a report of four cases with corticosteroid therapy to prolong gestation. J Reprod Med 1997; 42: 743-6.
7. Martin JN Jr, Blake PG, Perry KG Jr, McCaul JF, Hess LW, Martin RW: The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164: 1500-13.
8. Magann EF, Graves GR, Roberts WE, Blake PG, Morrison JC, Martin JN Jr: Corticosteroids for the enhanced fetal lung maturation in patients with HELLP syndrome: impact on neonates. Aust NZ J Obstet Gynaecol 1993; 33: 131-5.
9. Magann EF, Martin JN Jr, Martin RW, Isaacs JD, Blake PG, Morrison JC: Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome. Aust NZ J Obstet Gynaecol 1993; 33: 127-33.
10. Martin JN Jr, Ascarelli MH, Perry KG Jr, Magann EF, May WL, Blake PG: A birth weight of 600 grams: cutpoint on the cusp of perinatal viability in pregnancies delivered very preterm with HELLP syndrome. Journal of Maternal Fetal Investigation 1997; 7: 184-7.
11. Martin JN Jr, Martin RW, Perry KG Jr, Blake PG, Robinette L, Moore A: Better maternal outcomes are achieved using dexamethasone therapy for postpartum HELLP syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.
12. Navarro HA, Kudlacz EM, Eylers JP, Slotkin TA: Prenatal dexamethasone administration disrupts the pattern of cellular development in rat lung. Teratology 1989; 40: 433-8.